Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Alex Sapir
Person

Alex Sapir

Tracked across 2 events · 12 articles · First seen Jun 02, 2026 · Last active Aug 19, 2026

Sentiment
-5
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
4 -50
Business
Fulcrum Therapeutics stock plunges on FDA concerns
Impact: Alex Sapir, CEO of Fulcrum Therapeutics, made statements about pociredir's tolerability and competitive lead that are now under investigation for being potentially misleading prior to the FDA's safety concerns.
Jun 02, 2026 · 6 articles
4 40
Business
Fulcrum and Slate Medicines merger
Fulcrum Therapeutics and Slate Medicines have signed a definitive all-stock merger agreement to create a combined company focused on next-generation migraine treatments. The combined entity will operate as Slate Medicines and trade on Nasdaq under…
Impact: Alex Sapir, CEO of Fulcrum, led the strategic review and announced the merger, which provides a path forward for Fulcrum shareholders.
Aug 17, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Alex Sapir live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.